Genes in panel

Genetic Epilepsy

Gene: HCN2

Green List (high evidence)

HCN2 (hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2)
EnsemblGeneIds (GRCh38): ENSG00000099822
EnsemblGeneIds (GRCh37): ENSG00000099822
OMIM: 602781, ClinGen, DECIPHER
HCN2 is in 3 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

PMID 40468825 reports 21 individuals with HCN2 variants from 15 unrelated families. The phenotypic spectrum included developmental delay/intellectual disability (DD/ID, 17/21), epilepsy (10/21), language disorders (16/21), movement disorders (12/21), and axial hypotonia (10/21). Thirteen pathogenic variants (12 new and 1 already described) were identified: 11 missense (8 monoallelic and 3 biallelic), 1 recurrent inframe deletion (monoallelic), and 1 frameshift (biallelic). Functional analysis of p.(Arg324His) variant showed a strong increase of HCN2 conductance, whereas p.(Ala363Val) and p.(Met374Leu) exhibited dominant negative effects. The p.(Leu377His), p.(Pro493Leu), and p.(Gly587Asp) variants rendered HCN2 electrophysiologically silent and impaired membrane trafficking. Structural 3D-analysis revealed that, except for p.(Arg324His), all variants altered HCN2 stability.
Created: 23 Dec 2025, 3:22 p.m. | Last Modified: 23 Dec 2025, 3:22 p.m.
Panel Version: 1.320
Evidence for both mono-allelic and bi-allelic variants causing disease; also evidence for both GoF and LoF as mechanism.
Created: 23 Jan 2020, 10:04 p.m. | Last Modified: 23 Jan 2020, 10:04 p.m.
Panel Version: 0.304
Single family with bi-allelic loss-of-function variants reported in the literature (two papers refer to same family).
Created: 20 Nov 2019, 2:32 p.m. | Last Modified: 20 Nov 2019, 2:32 p.m.
Panel Version: 0.0

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Febrile seizures, familial, 2, MIM# 602477; Genetic epilepsy with febrile seizures plus; Other seizure disorders

Publications

Mode of pathogenicity
Other

Variants in this GENE are reported as part of current diagnostic practice

Details

Mode of Inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
  • Australian Genomics Health Alliance Epilepsy Flagship
Phenotypes
  • Generalized epilepsy with febrile seizures plus, type 11, MIM# 602477
  • Febrile seizures, familial, 2, MIM# 602477
  • Genetic epilepsy with febrile seizures plus
  • Other seizure disorders
OMIM
602781
ClinGen
HCN2
DECIPHER
HCN2
Clinvar variants
Variants in HCN2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

23 Dec 2025, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: HCN2 were changed from Febrile seizures, familial, 2, MIM# 602477; Genetic epilepsy with febrile seizures plus; Other seizure disorders to Generalized epilepsy with febrile seizures plus, type 11, MIM# 602477; Febrile seizures, familial, 2, MIM# 602477; Genetic epilepsy with febrile seizures plus; Other seizure disorders

23 Dec 2025, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: HCN2 were set to 22131395; 30986657; 29064616; 20437590; 12514127; 17931874

20 Sep 2021, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: HCN2 were changed from Genetic epilepsy with febrile seizures plus; Other seizure disorders to Febrile seizures, familial, 2, MIM# 602477; Genetic epilepsy with febrile seizures plus; Other seizure disorders

23 Jan 2020, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: HCN2 were changed from to Genetic epilepsy with febrile seizures plus; Other seizure disorders

23 Jan 2020, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: HCN2 were set to

23 Jan 2020, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: HCN2 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal

23 Jan 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: hcn2 has been classified as Green List (High Evidence).

20 Nov 2019, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: hcn2 has been classified as Amber List (Moderate Evidence).

20 Nov 2019, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: hcn2 has been classified as Amber List (Moderate Evidence).

18 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: HCN2 was added gene: HCN2 was added to Genetic Epilepsy_AustralianGenomics_VCGS. Sources: Australian Genomics Health Alliance Epilepsy Flagship,Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: HCN2 was set to Unknown